Allogene Therapeutics Ownership | Who Owns Allogene Therapeutics?
Allogene Therapeutics Ownership Summary
Allogene Therapeutics is owned by 44.72% institutional investors, 16.63% insiders, and 38.65% retail investors. Pfizer is the largest institutional shareholder, holding 9.92% of ALLO shares. American Funds SMALLCAP World A is the top mutual fund, with 5.10% of its assets in Allogene Therapeutics shares.
ALLO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Allogene Therapeutics | 44.72% | 16.63% | 38.65% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Pfizer | 22.03M | 9.92% | $30.18M |
| Blackrock | 16.45M | 9.72% | $38.32M |
| Tpg gp a | 18.72M | 8.55% | $23.21M |
| Blackrock funding, inc. /de | 17.68M | 7.96% | $24.22M |
| Vanguard group | 9.25M | 4.17% | $12.67M |
| Primecap management co/ca/ | 8.14M | 3.67% | $11.15M |
| Patient square capital lp | 4.96M | 2.24% | $6.80M |
| Woodline partners lp | 4.36M | 1.99% | $5.41M |
| Geode capital management | 3.93M | 1.77% | $5.39M |
| Frazier life sciences management | 3.87M | 1.77% | $4.80M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pfizer | 22.03M | 12.76% | $30.18M |
| Vida ventures advisors | 1.80M | 7.59% | $2.23M |
| Wildcat capital management | 2.92M | 2.93% | $4.00M |
| Patient square capital lp | 4.96M | 1.46% | $6.80M |
| Tpg gp a | 18.72M | 1.26% | $23.21M |
| Dafna capital management | 1.38M | 0.42% | $1.71M |
| Frazier life sciences management | 3.87M | 0.14% | $4.80M |
| Lynx1 capital management lp | 546.12K | 0.14% | $677.19K |
| Harold davidson & associates | 194.75K | 0.12% | $266.81K |
| Moloney securities asset management | 514.00K | 0.08% | $637.36K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 16.45M | 0.00% | 6.79M |
| Patient square capital lp | 4.96M | 1.46% | 1.98M |
| Two sigma investments, lp | 3.38M | 0.01% | 1.77M |
| Goldman sachs group | 2.29M | 0.00% | 1.09M |
| Primecap management co/ca/ | 8.14M | 0.01% | 1.06M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -11.15M |
| Lynx1 capital management lp | 546.12K | 0.14% | -10.51M |
| Darwin global management | - | - | -10.48M |
| Boxer capital | - | - | -3.85M |
| Foresite capital management vi | - | - | -2.88M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jacobs levy equity management | 878.96K | 0.01% | 878.96K | $2.05M |
| Bridgeway capital management | 250.00K | 0.01% | 250.00K | $310.00K |
| Tema etfs | 219.07K | 0.04% | 219.07K | $534.54K |
| Headlands | 139.96K | 0.01% | 139.96K | $173.55K |
| Cubist systematic strategies | 102.77K | 0.00% | 102.77K | $127.44K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -41.00 |
| Raymond james financial | -45.00 |
| Dunhill financial | -70.00 |
| Pnc financial services group | -85.00 |
| Federation des caisses desjardins du quebec | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 108 | -37.93% | 99,292,779 | -38.89% | 44 | 0.81% | 46 | -51.06% | 31 | -16.22% |
| Sep 30, 2025 | 166 | 8.50% | 162,395,329 | -2.90% | 74 | 1.27% | 85 | 26.87% | 37 | -11.90% |
| Jun 30, 2025 | 160 | -6.98% | 183,929,908 | -6.69% | 84 | 1.00% | 66 | -27.47% | 47 | 14.63% |
| Mar 31, 2025 | 170 | -1.73% | 196,870,758 | 4.48% | 91 | 1.13% | 90 | -2.17% | 41 | - |
| Dec 31, 2024 | 165 | 5.10% | 185,488,005 | 12.84% | 88 | 1.44% | 89 | 27.14% | 40 | -11.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 11.15M | 5.10% | -1.12M |
| Vanguard Capital Opportunity Inv | 5.19M | 2.31% | 768.93K |
| Fidelity Growth Compy Commingled Pl O | 4.58M | 2.19% | - |
| State Street® SPDR® S&P® Biotech ETF | 5.21M | 2.14% | 79.83K |
| Vanguard Total Stock Mkt Idx Inv | 4.88M | 2.13% | - |
| Vanguard US Total Market Shares ETF | 4.34M | 2.00% | - |
| Fidelity Select Health Care | 4.00M | 1.88% | -350.00K |
| SPDR® S&P Biotech ETF | 3.90M | 1.84% | -23.78K |
| Fidelity Series Small Cap Opps | 3.54M | 1.69% | -141.30K |
| iShares Russell 2000 ETF | 3.80M | 1.56% | -31.07K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 31, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $7.17K |
| Mar 16, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $11.94K |
| Mar 16, 2026 | Chang David D | President and CEO | Sell | $117.97K |
| Mar 02, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $18.54K |
| Feb 02, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | $13.06K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 11 |
| 2025 Q4 | - | 2 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 9 |
| 2024 Q4 | - | 2 |
ALLO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools